Publication | Closed Access

Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy

Cancer ResearchOncologyMedicinePathologyBronchial NeoplasmCaveolin-1 ExpressionPoor PrognosisAnti-cancer AgentCancer TreatmentPharmacologyTumor MicroenvironmentLung CancerTumor BiologyDrug Resistance